Literature DB >> 32659787

Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Michael J Rybak1,2,3, Jennifer Le4, Thomas Lodise5,6, Donald Levine3,7, John Bradley8,9, Catherine Liu10,11, Bruce Mueller12, Manjunath Pai12, Annie Wong-Beringer13, John C Rotschafer14, Keith Rodvold15, Holly D Maples16, Benjamin M Lomaestro17.   

Abstract

Entities:  

Keywords:  nephrotoxicity; pharmacokinetics and pharmacodynamics; target attainment; vancomycin; vancomycin consensus guidelines

Mesh：

Substances：

Year:  2020        PMID： 32659787      PMCID： PMC7358040          DOI： 10.1093/jpids/piaa057

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


× No keyword cloud information.
  2 in total

1.  The periodic health examination. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

2.  Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Jennifer Le; Thomas P Lodise; Donald P Levine; John S Bradley; Catherine Liu; Bruce A Mueller; Manjunath P Pai; Annie Wong-Beringer; John C Rotschafer; Keith A Rodvold; Holly D Maples; Benjamin M Lomaestro
Journal:  Am J Health Syst Pharm       Date:  2020-05-19       Impact factor: 2.637
  2 in total
  5 in total

1.  Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program.

Authors:  Lore Thijs; Charlotte Quintens; Lotte Vander Elst; Paul De Munter; Melissa Depypere; Willem-Jan Metsemakers; Georges Vles; Astrid Liesenborghs; Jens Neefs; Willy E Peetermans; Isabel Spriet
Journal:  Antibiotics (Basel)       Date:  2022-05-23

2.  Population pharmacokinetics and dose optimization of vancomycin in neonates.

Authors:  Soon Min Lee; Seungwon Yang; Soyoung Kang; Min Jung Chang
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

3.  Prediction of Unbound Vancomycin Levels in Intensive Care Unit and Nonintensive Care Unit Patients: Total Bilirubin May Play an Important Role.

Authors:  Xiao Li; Wen Xu; Ran Li; Qie Guo; Xiangpeng Li; Jialin Sun; Shuhong Sun; Jing Li
Journal:  Infect Drug Resist       Date:  2021-07-02       Impact factor: 4.003

4.  Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin.

Authors:  Jasmine H Hughes; Dominic M H Tong; Sarah Scarpace Lucas; Jonathan D Faldasz; Srijib Goswami; Ron J Keizer
Journal:  Clin Pharmacol Ther       Date:  2020-11-21       Impact factor: 6.903

5.  Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis.

Authors:  Melissa J Karau; Suzannah M Schmidt-Malan; Scott A Cunningham; Jayawant N Mandrekar; Bobbi S Pritt; Tiffany R Keepers; Alisa W Serio; Surya Chitra; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2021-11-01       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.